<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744053/" ref="ordinalpos=2582&amp;ncbi_uid=5213585&amp;link_uid=PMC3744053" image-link="/pmc/articles/PMC3744053/figure/F5/" class="imagepopup">Figure 5.  From: Vascular Permeability and Drug Delivery in Cancers. </a></div><br /><div class="p4l_captionBody"><b>Signaling pathways of anti-permeability factors</b>. The most relevant anti-permeability factors are angiopoietin-1 (Ang1), sphingosine-1-phosphate (S1P), and fibroblast growth factor (FGF). Ang1 activation of its cognate receptor, Tie2, elicits a signaling pathway and promotes Src sequestration; thus hindering VEGF-A signaling and VE-cadherin internalization. S1P signaling maintains vascular integrity by modulating VE-cadherin internalization, cytoskeletal rearrangement, barrier enhancement and integrity, through its cognate receptor S1P1R. FGF maintains the integrity of the VE-cadherin/p120-catenin complex, thus stabilizing VE-cadherin at the membrane.</div></div>